Saba Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-415,330
| Closed | -$4.05M | – | 932 |
|
|
2022
Q3 | $4.05M | Hold |
415,330
| – | – | 0.05% | 531 |
|
|
2022
Q2 | $4.03M | Hold |
415,330
| – | – | 0.05% | 541 |
|
|
2022
Q1 | $4.03M | Hold |
415,330
| – | – | 0.06% | 467 |
|
|
2021
Q4 | $4.02M | Buy |
415,330
+150,200
| +57% | +$1.45M | 0.06% | 400 |
|
|
2021
Q3 | $2.57M | Buy |
+265,130
| New | +$2.57M | 0.06% | 319 |
|